Pharmacutical Urolithiasis Management Devices Market | Page 2

REPORT DESCRIPTION
Urolithiasis Management Devices Market : Overview
On the basis of region, the global urolithiasis management devices market is
segmented into North America, Latin America, Europe, Asia Pacific, Middle East,
and Africa. North America holds a dominant position in the global urolithiasis
management devices market and is expected to retain its dominance over the
forecast period, owing to presence of a large patient pool suffering from
urolithiasis. According to the University of Wisconsin Foundation 2013, the
incidence of urolithiasis is estimated to be 13% in men and 7% in females in the
U.S. Moreover, high presence of leading market players developing innovative and
technologically advanced products for the treatment of the kidney disorders in the
region is also expected to fuel growth of the regional market. For instance, in 2017
Dornier MedTech, an Atlanta-based medical device company, introduced
DORNIER DELTA III, an advanced kidney stone treatment lithotripter that
facilitates enhanced efficiency, maximized energy and powerful imaging with its
patent protected 'Unified Hand Control' for ease of use and time-saving workflow.
© Coherent market Insights. All Rights Reserved